RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL)
CUSIP: 766559702
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 18,617,462
- Total 13F shares
- 13,883,445
- Share change
- +8,178
- Total reported value
- $260,032,689
- Put/Call ratio
- 0%
- Price per share
- $18.73
- Number of holders
- 121
- Value change
- +$336,299
- Number of buys
- 60
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 766559702?
CUSIP 766559702 identifies RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 766559702:
Top shareholders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
1,732,604
|
$31,169,546 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
8.5%
|
1,516,000
|
$28,894,960 | +$6,937,840 | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
8.3%
|
1,536,987
|
$27,650,397 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
6.1%
|
1,130,679
|
$20,340,915 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
1,028,072
|
$18,495,015 | — | 31 Mar 2025 | |
| Capitolis Liquid Global Markets LLC |
13F
|
Company |
3.7%
|
693,100
|
$12,468,869 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
637,034
|
$11,460,242 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3%
|
565,045
|
$10,161,000 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.8%
|
522,781
|
$9,404,830 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
411,168
|
$7,398,878 | — | 31 Mar 2025 | |
| CM Management, LLC |
13F
|
Company |
1.3%
|
250,000
|
$4,497,500 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.2%
|
217,776
|
$3,917,790 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.1%
|
211,748
|
$3,809,347 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
201,146
|
$3,618,617 | — | 31 Mar 2025 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
1%
|
192,164
|
$3,457,031 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.85%
|
157,924
|
$2,841,053 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.83%
|
154,617
|
$2,781,560 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
142,459
|
$2,562,838 | — | 31 Mar 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.72%
|
134,363
|
$2,417,000 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
13D/G
|
Company |
0.03%
from 13D/G
|
134,072
|
$2,411,955 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.71%
|
132,437
|
$2,382,541 | — | 31 Mar 2025 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.69%
|
128,088
|
$2,304,302 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.62%
|
115,218
|
$2,072,771 | — | 31 Mar 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.6%
|
112,629
|
$2,026,196 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.59%
|
110,384
|
$1,985,808 | — | 31 Mar 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.56%
|
104,455
|
$1,879,145 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.46%
|
86,176
|
$1,550,307 | — | 31 Mar 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.42%
|
77,570
|
$1,395,484 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
66,337
|
$1,193,403 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.35%
|
65,300
|
$1,174,747 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.33%
|
61,398
|
$1,104,550 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
59,474
|
$1,069,938 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
55,427
|
$997,132 | — | 31 Mar 2025 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.28%
|
52,295
|
$940,787 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
49,572
|
$891,801 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.26%
|
48,874
|
$879,243 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
47,470
|
$853,985 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
46,715
|
$840,403 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.24%
|
44,686
|
$804,000 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
41,928
|
$754,285 | — | 31 Mar 2025 | |
| Jackson Creek Investment Advisors LLC |
13F
|
Company |
0.2%
|
38,045
|
$684,000 | — | 31 Mar 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.19%
|
36,001
|
$647,658 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.18%
|
33,369
|
$600,308 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.18%
|
33,101
|
$595,487 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.17%
|
31,473
|
$566,199 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
30,953
|
$556,844 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.17%
|
30,851
|
$555,009 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
30,172
|
$542,794 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
29,211
|
$525,506 | — | 31 Mar 2025 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.15%
|
27,117
|
$488,000 | — | 31 Mar 2025 |
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.